Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy

Author： Yamada Takeshi   Nakayama Masashi   Shimizu Tomohito   Nonen Shinpei   Nakai Yasutomo   Nishimura Kazuo   Fujio Yasushi   Okuyama Akihiko   Azuma Junichi   Nonomura Norio  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.4, 2013-08, pp. : 711-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean

By Eom Sang-Yong   Yim Dong-Hyuk   Zhang Yanwei   Yun Jung-Kuk   Moon Sun   Yun Hyo-Yung   Song Young-Jin   Youn Sei-Jin   Hyun Taisun   Park Joo-Seung   Kim Byung   Lee Jong-Young   Kim Yong-Dae   Kim Heon  

Cancer Causes and Control, Vol. 24, Iss. 11, 2013-11 ,pp. : 1963-1972

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism

By  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 295-295

Springer Publishing Company

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S   Gao Allen C  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite

CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation

By Ng Daniel   Tan Kar-Wai   Zhao Bin   Seow Adeline  

Cancer Causes and Control, Vol. 16, Iss. 4, 2005-05 ,pp. : 399-405

Springer Publishing Company

Access to resources Recommend Favorite

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer

By Lucarelli Giuseppe   Ditonno Pasquale   Bettocchi Carlo   Spilotros Marco   Rutigliano Monica   Vavallo Antonio   Galleggiante Vanessa   Fanelli Margherita   Larocca Angela Maria Vittoria   Germinario Cinzia Annatea   Maiorano Eugenio   Selvaggi Francesco Paolo   Battaglia Michele  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 899-907

Future Medicine

Access to resources Recommend Favorite